811 related articles for article (PubMed ID: 16698706)
1. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
[TBL] [Abstract][Full Text] [Related]
2. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
6. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
7. [Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors].
Schneider K; Hrasky A; Aschoff P; Bihl H; Hagen R
Laryngorhinootologie; 2006 Nov; 85(11):819-23. PubMed ID: 16612756
[TBL] [Abstract][Full Text] [Related]
8. Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.
Dequanter D; Lothaire P; Gastelblum P; Nguyen TH; Lalami Y; Awada A; Andry G
B-ENT; 2008; 4(3):157-61. PubMed ID: 18949962
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP).
Haas I; Hoffmann TK; Engers R; Ganzer U
Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):325-33. PubMed ID: 12115082
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
Issing WJ; Taleban B; Tauber S
Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
Boscolo-Rizzo P; Gava A; Da Mosto MC
Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
[TBL] [Abstract][Full Text] [Related]
12. Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary.
Hauswald H; Lindel K; Rochet N; Debus J; Harms W
Strahlenther Onkol; 2008 Mar; 184(3):150-6. PubMed ID: 18330511
[TBL] [Abstract][Full Text] [Related]
13. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
Waltonen JD; Ozer E; Hall NC; Schuller DE; Agrawal A
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1024-9. PubMed ID: 19841343
[TBL] [Abstract][Full Text] [Related]
14. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumour.
Mevio E; Gorini E; Sbrocca M; Artesi L; Mullace M; Caimi F
Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):342-7. PubMed ID: 15952684
[TBL] [Abstract][Full Text] [Related]
15. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of isolated neck metastases of adenocarcinomas.
Zuur CL; van Velthuysen ML; Schornagel JH; Hilgers FJ; Balm AJ
Eur J Surg Oncol; 2002 Mar; 28(2):147-52. PubMed ID: 11884050
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node metastases in the neck of unknown primary tumor].
Koscielny S; Gudziol H; Kretzschmar J
Laryngorhinootologie; 2000 Aug; 79(8):483-9. PubMed ID: 11006913
[TBL] [Abstract][Full Text] [Related]
18. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
19. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
20. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
